Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Danshen Dripping Pills
- Development stage
- Unknown
- Lead developer
- Tasly Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral, Sublingual
01
Overview
Compound Danshen Dripping Pills (CDDP), also known as T89, is a standardized traditional Chinese medicine (TCM) composite formulation developed by Tasly Pharmaceutical. It is primarily composed of extracts from *Salvia miltiorrhiza* (Danshen), *Panax notoginseng* (Sanchi), and Borneol. The drug is widely utilized for the prevention and treatment of cardiovascular conditions, particularly coronary artery disease and angina pectoris. Its therapeutic effects are attributed to its ability to improve coronary blood flow, inhibit platelet aggregation, and reduce myocardial oxygen consumption through anti-inflammatory and antioxidant pathways. CDDP holds the distinction of being the first TCM formulation to successfully complete a Phase II clinical trial under the U.S. FDA's Investigational New Drug (IND) application and has been approved for clinical use in China for over two decades.
- Brand names
- Compound Danshen Dripping Pills
- Other names
- Fufang Danshen DiwanDanshen PlusTasly T89
02
Targets
NO2- (Nitrite)
Beyond the preview
Go deeper on Compound Danshen Dripping Pills.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Compound Danshen Dripping Pills.